ClinicaliQ Trial Snapshot
- COVID-19 Omicron BA.5 Subvariant Dose Finding Infection Study — Active Not Recruiting • Phase I • Infectious Disease • NCT06478420.
- Researchers tested different doses of Omicron BA.5 virus in vaccinated volunteers to find the optimal dose for future COVID vaccine studies.
Verify eligibility, endpoints and current status on the original ClinicalTrials.gov registry before acting on this summary.
Use This Page For
- Quick orientation before opening the registry record.
- Checking recruitment status, phase and sponsor at a glance.
- Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying
A phase 1, dose-finding open label clinical infection, safety and viral detection optimization in healthy volunteers immunologically experienced against SARS-CoV-2. Conditions: SARS-CoV-2 Infection Interventions: Omicron BA.5 SARS-CoV-2 challenge virus Lead Sponsor: University of Oxford Planned Enrollment: 45 participants